RecruitingNCT05334940
Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases
Sponsor
Charite University, Berlin, Germany
Enrollment
600 participants
Start Date
Dec 8, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The Atopy Registry aims to assess data about atopic disorders and their medical care in a standardized form. With this, the comparative efficacy, tolerability and safety of systemic therapies for atopic disorders should be investigated. An optional additional module "Bioanalytic" shall provide insights into further connections regarding immunology, genetics and microbiome.
Eligibility
Min Age: 6 Years
Inclusion Criteria3
- patients are at least 6 years old
- patients with a proven moderate to severe atopic disorder who are planned to receive a biologic systemic therapy
- at least one additional proven atopic disorder
Exclusion Criteria3
- <2 atopic disorders
- poor compliance
- pregnancy or breastfeeding
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERnot applicable, observational study
Patients do not receive intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05334940